Elo Health

Elo Health is a San Francisco-based company offering personalized nutrition solutions. They use data from at-home blood tests, wearables, and health questionnaires to tailor supplements and protein blends to individual needs. Their products include Smart Supplements, Smart Protein, and 3D-printed Smart Gummies, all designed to support specific health goals. Elo's approach aims to transform food from a cause of disease into a form of medicine by providing precise, science-backed nutrition.

In a B2B2C partnership with US Fertility, they have developed Luminary Vitamins: doctor-formulated, stage-specific nutrient gummies designed to support individuals throughout their reproductive journey—from preconception to postpartum. Their product line includes options like "Create" for preconception, "Form" and "Flourish" for pregnancy stages, and "Nurture" for postpartum recovery, each tailored to meet the unique nutritional needs of each phase.

The company also provides an iOS app that allows users to track their supplement intake, manage subscriptions, and receive personalized nutrition content. This digital companion aims to enhance user engagement and ensure consistency in supplement use.

‍

Nutrient and caloric imbalances give rise to chronic non-communicable diseases at alarming rates, representing the world’s leading cause of poor human health. 17% of the U.S. GDP is spent on healthcare (World Bank), out of which +25% is spent on preventable illnesses, primarily driven by unhealthy diets and lack of exercise.

The feedback loop between daily nutrition and long-term health is often delayed by decades, making it difficult for individuals to take corrective action early to minimize long-term, preventable diseases.

With Elo’s solutions, people can detect risk factors, such as high cholesterol or blood sugar, early and take preventative steps to prevent future diet-related diseases.

Shifting to healthier diets could reduce annual healthcare costs in the US alone by up to $50 billion, currently spent on diet-related diseases , and prevent 20% of all premature deaths globally.